baraclude 0.5 mg
bristol - myers squibb, israel - entecavir; entecavir - film coated tablets - entecavir 0.5 mg; entecavir 0.5 mg - entecavir - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease. baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.
baraclude
bristol-myers squibb pharma eeig - entecavir - hepatitis b, chronic - antivirals for systemic use - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with:compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis;decompensated liver disease.for both compensated and decompensated liver disease, this indication is based on clinical trial data in nucleoside naive patients with hbeag positive and hbeag negative hbv infection. with respect to patients with lamivudine-refractory hepatitis b.
entecavir 0.5 milligram film coated tablet
actavis uk limited - entecavir monohydrate - film coated tablet - 0.5 milligram - nucleoside and nucleotide reverse transcriptase inhibitors
entecavir 1 milligram film coated tablet
actavis uk limited - entecavir monohydrate - film coated tablet - 1 milligram - nucleoside and nucleotide reverse transcriptase inhibitors
baraclude 0.5mg tablets
bristol-myers squibb pharmaceuticals ltd - entecavir monohydrate - tablet - 500microgram
baraclude 1mg tablets
bristol-myers squibb pharmaceuticals ltd - entecavir monohydrate - tablet - 1mg
entecavir 500microgram tablets
dr reddy's laboratories (uk - entecavir monohydrate - tablet - 500microgram
entecavir 1mg tablets
dr reddy's laboratories (uk - entecavir monohydrate - tablet - 1mg
entecavir accord
accord healthcare s.l.u. - entecavir - hepatitis b, chronic - antivirals for systemic use - entecavir accord is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: , compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis., decompensated liver disease. , for both compensated and decompensated liver disease, this indication is based on clinical trial data in nucleoside naive patients with hbeag positive and hbeag negative hbv infection. with respect to patients with lamivudine-refractory hepatitis b. entecavir accord is also indicated for the treatment of chronic hbv infection in nucleoside naive paediatric patients from 2 to
entecavir farma job 0.5mg film-coated tablets
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - entecavir hydrate - film-coated tablet - entecavir hydrate 0.5 mg - antivirals for systemic use